Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286

BACKGROUND: Resistance development to paclitaxel (PTX) has become a major obstacle in the successful treatment of breast cancer (BC). Circular RNAs (circRNAs) have been identified as essential regulators in PTX resistance of BC. Here, we explored the precise roles of circRNA homeodomain interacting...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Jun, Xi, Xun, Xiao, Sujian, Xiao, Xigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285247/
https://www.ncbi.nlm.nih.gov/pubmed/34285578
http://dx.doi.org/10.2147/CMAR.S307595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285247/
https://www.ncbi.nlm.nih.gov/pubmed/34285578
http://dx.doi.org/10.2147/CMAR.S307595

Ejemplares similares